Congress aims to lower prescription prices by regulating the practices of pharmacy benefit managers (PBMs), companies that lawmakers say drive up costs, creating hardship for patients and small businesses and an added burden to taxpayers.
PBMs, which are largely invisible to the general public, negotiate the prices insurers pay for medications, determine the amount consumers pay, and process insurance drug claims.
